SDS-PAGE. Antigen binding was investigated by CCP3 ELISA. VH-VL structure models were generated using the online tool PIGS and visualised by Jmol, and the GlyProt server was utilised for in silico glycosylation. Results The majority of ACPA exhibited variable region Nlinked motifs (83.8%), compared to 14.3% of non-ACPA RA mAbs and 63.2% of bnAbs, featured in both framework and CDRs. When adjusted for SHM, N-linked motifs were significantly increased in ACPA compared to non-ACPA RA mAbs (p=0.001) or bnAbs (p=0.002). VH region motif rates were increased in ACPA compared to non-ACPA mAbs (p=0.002) and bnAbs (p=0.0004), while VL region motifs were only higher compared to non-ACPA (p=0.002). Deglycosylation revealed that N-linked motifs were indeed glycosylated, although preliminary data suggests glycan removal had no striking effect on antigen-binding. Homology-based structures predicted glycans to be primarily positioned outside of the potential antigen-binding site. Conclusions The results support that variable region glycosylation is a key feature of ACPA. Significant increases in Nlinked motifs in ACPA compared to other highly-mutated antibodies signifies that this is not solely linked to hypermutation. Future studies are merited to further investigate the selection mechanisms and functional role of Fab-glycosylated autoantibodies. Background Anti-citrullinated protein/peptide antibodies (ACPA) represent an important tool for the diagnosis of RA and the presence of multiple ACPA specificities is highly correlated with the evolution towards RA. 1 However, a limited amount of information is available on the predictive value of single specificities on disease manifestations and response to therapy in established RA
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ACPA FINGERPRINTING IN ESTABLISHED RHEUMATOID ARTHRITIS
Background
Anti-citrullinated protein/peptide antibodies (ACPA) represent an important tool for the diagnosis of RA and the presence of multiple ACPA specificities is highly correlated with the evolution towards RA. 1 However, a limited amount of information is available on the predictive value of single specificities on disease manifestations and response to therapy in established RA
The aim of the present work is to evaluate the diagnostic and prognostic value of the combined use of four well established citrullinated peptides as antigens for ACPA detection: VCP1 and VCP2 (derived from EBV proteins) and HCP1 and HCP2 (derived from histone H4).
2,3
Materials and methods Four hundred and forty-eight RA patients, followed in the Clinical Immunology Unit, University of Pisa, and in the Rheumatology Unit, University of Perugia, were recruited.
RA patients were evaluated for systemic involvement, disease activity and severity, ongoing and past therapies.
Anti-VCP1, -VCP2, -HCP1, -HCP2 were measured by home-made ELISA.
Data were analysed by cluster analysis and principal component analysis. Results Antibodies to VCP1 were detected in 52% of RA patients; anti-VCP2 in 59,5%; anti-HCP1 in 57% and anti-HCP2 in 57,5%
Cluster analysis and principal component analysis identify two subpopulations, that differ for ACPA levels, RF positivity, lung involvement and higher use of biological therapy.
Patients were also subdivided in 5 groups according to the number of anti-peptide antibodies (negative for any, positive for one, for two, for three, for four). Mean antibody level and RF positivity progressively increased from the first to the last group, as well as the frequency of lung involvement. Conclusions ACPA are a family of antibodies with overlapping specificities. The results obtained with citrullinated peptides from EBV proteins and histone H4 suggest that fingerprinting of ACPA may be informative in established RA. A higher number of ACPA subtypes is predictive of lung involvement. Moreover, a broader ACPA repertoire also emerged as a feature of patients treated with biological therapy, thus probably affected by a more severe form of the disease.
In conclusion, ACPA typing may be relevant for a better characterisation of some disease features in established RA.
DOMINANT B-CELL RECEPTOR CLONES IN PERIPHERAL BLOOD PREDICT ONSET OF ARTHRITIS IN INDIVIDUALS AT RISK FOR RHEUMATOID ARTHRITIS
Background The onset of seropositive rheumatoid arthritis (RA) is preceded by the presence of specific autoantibodies in the absence of synovial inflammation. Only a subset of these at-risk individuals will develop clinical disease. This impedes efforts to implement early interventions that may prevent onset of clinical disease. Here we analyse whether clonal changes in the B-cell receptor (BCR) repertoire can reliably predict onset of clinical disease. Methods In a prospective cohort study in 21 individuals atrisk for RA, the BCR repertoire of paired peripheral blood and synovial tissue samples was analysed using next-generation BCR sequencing. BCR clones that were expanded beyond 0.5% of the total repertoire were labelled dominant. The relative risk for onset of arthritis was assessed, using a cut-off of presence of !5 dominant BCR clones. Findings in peripheral blood were validated in an independent prospective cohort of 50 at-risk individuals. Based on the test cohort, individuals in the validation cohort were considered positive if peripheral blood at study entry showed !5 dominant BCR clones.
Results Both in the test and validation cohort, the presence of !5 dominant BCR clones in peripheral blood was significantly associated with arthritis development (validation cohort relative risk (RR) 6.3, 95% confidence interval (CI) 2.7-15, p<1*10 -4 ). Even when adjusted for the recently described clinical prediction rule the association remained intact (relative risk 5.0, 95% CI 1.2-20, p=0.024). When individuals developed arthritis, dominant BCR clones disappeared from peripheral blood and appeared in synovial tissue, suggesting a direct role of these clones in disease pathogenesis. Conclusion Dominant BCR clones in peripheral blood predict onset of clinical symptoms of RA in at-risk individuals with high accuracy. Our data suggest that during onset of RA these clones shift from peripheral blood to target tissue. Background TNF plays a key role in immune-mediated inflammatory diseases including rheumatoid arthritis (RA) and spondyloarthritis (SpA). Here we aimed to investigate how TNF can lead to completely different disease phenotypes such as destructive peripheral polysynovitis in RA versus axial and peripheral remodelling arthritis in SpA. Materials and methods We assessed expression of TNF, TNF-R, and TACE (ADAM17) in synovial fluid, synovial tissue, and synovial fibroblasts from SpA and RA. tmTNFtg mice (TgA86) 1 were clinically scored for development of peripheral and axial disease, and sacrificed at the end of the experiments for radiologic and histologic assessment. Mechanistic studies included bone marrow chimaera experiments and crossing with TNF-R1 or TNF-R2 knock-out animals. Results Arthritis was characterised by lower levels of sTNF and higher levels of tmTNF in SpA versus RA. This misbalance was related to decreased TACE activity in SpA versus RA FLS, as further confirmed by lower levels of other soluble molecules cleaved by TACE (including sTNF-RI, sTNF-RII, and sCD163) in the inflamed SpA joint. Assessing whether tmTNF has a functional role in SpA pathology, mice selectively over-expressing the transmembrane form of TNF spontaneously developed a deforming arthritis and spondylitis, starting at 4 weeks of age and reaching a 100% incidence. Histology revealed peripheral and axial synovitis, enthesitis, and osteitis, as well as inflammation of the connective tissue located at the junction of the annulus fibrosus with the vertebral bone. tmTNFtg mice did not develop extra-articular inflammation. Structural phenotyping by histology and radiology revealed mild destructive features in combination with foci of hypertrophic chondrocytes and axial and peripheral new bone formation leading to bridging of tail vertebra over time. Mechanistic experiments revealed that this SpA-like phenotype was mediated by tmTNF expression on stromal cells but not on hematopoietic cells and required the expression of TNF-R1.
THE ROLE OF TRANSMEMBRANE RATHER THAN SOLUBLE TNF IN SPONDYLOARTHRITIS
Conclusions Collectively, these data suggest that tmTNF expressed by stromal cells is responsible for the key pathological features of SpA. Background The ubiquitously expressed transmembrane heparan sulfate proteoglycan Syndecan-4 (Scd4) is crucial in inflammatory diseases, like rheumatoid arthritis. Depending on the tissue, it can either protect or promote an inflammatory process. By its binding of molecules, such as cytokines and growth factors, it can initiate signalling pathways and it has been implicated in cell-matrix adhesion, cell migration, differentiation as well as proliferation. However, the involvement of Sdc4 in intestinal inflammation is unknown so far. Our group revealed a protective function of Sdc4 in experimental intestinal inflammation. Material and methods We monitored the course of DSSinduced colitis in Scd4 -/-and C57BL/6 WT mice and analysed the changes in body weight, colon length, histology and inflammatory cellular infiltrate. We also evaluated Sdc4 protein-and mRNA-level by immunofluorescence staining (IF) and quantitative real-time PCR. Colon-permeability was examined in vivo by using the Evans Blue method and measuring the clearance for Citrobacter rodentium in vivo. Wound healing effects of Scd4 were analysed in vitro by scratch assay analysis with human epithelial colon cell line (T-84) and in vivo by mechanically induced wounds in colonoscopies of Scd4 -/-compared to WT mice. Results The expression of Scd4 is decreased upon the course of colitis and increased during remission. The course of colitis was markedly aggravated in Scd4 -/-mice, reflected by dramatically loss of body weight, increased mortality rates and histological damage, emphasised by increased invasion of macrophages and granulocytes into the colon. Also colonic epithelial permeability of DSS-treated Scd4 -/-mice was enhanced associated with an altered expression of tight junction proteins. Furthermore, Sdc4 deficiency resulted in a prolonged intestinal wound healing in vitro and in vivo due to reduced proliferation rates in vitro. Conclusions Our data indicates that Scd4 is crucial in experimental intestinal inflammation. It exerts protective effects by maintaining epithelial barrier integrity and regeneration. Further studies are needed to explore the mechanisms of Sdc4-signalling in colitis.
